| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.19B | +12.9% |
| Cost of Revenue | $439.6M | +17.0% |
| Gross Profit | $755.0M | +10.6% |
| R&D Expense | $94.8M | +12.3% |
| SG&A Expense | $574.0M | +13.3% |
| Operating Income | $9.3M | -87.4% |
| Pre-tax Income | $20.9M | -73.8% |
| Income Tax | $6.9M | +160.7% |
| Net Income | $14.0M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $324.4M | +93.7% |
| Accounts Receivable | $167.7M | -16.9% |
| Inventory | $406.7M | +4.8% |
| Current Assets | $951.1M | +3.9% |
| Total Assets | $1.53B | -1.5% |
| Current Liabilities | $158.3M | +4.8% |
| Total Liabilities | $382.3M | +1.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $168.5M | +73.1% |
| Capital Expenditures | $21.2M | +39.2% |
| Investing Cash Flow | $77.6M | +582.9% |
| Financing Cash Flow | -$87.0M | -637.0% |
| Free Cash Flow | $147.3M | +79.4% |
| -84.6% |
| EPS (Basic) | $0.36 | -84.8% |
| EPS (Diluted) | $0.36 | -84.5% |
| Stockholders' Equity |
| $1.15B |
| -2.4% |